Bank of Montreal’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$41.2M Sell
210,365
-7,019
-3% -$1.36M 0.02% 604
2025
Q4
$37.7M Buy
217,384
+14,782
+7% +$2.69M 0.01% 656
2025
Q3
$38.6M Buy
202,602
+640
+0.3% +$114K 0.01% 584
2025
Q2
$36.3M Sell
201,962
-10,296
-5% -$1.79M 0.02% 528
2025
Q1
$35.9M Sell
212,258
-13,558
-6% -$2.23M 0.02% 528
2024
Q4
$34.1M Sell
225,816
-51,580
-19% -$8.02M 0.02% 573
2024
Q3
$42.9M Buy
277,396
+10,860
+4% +$1.62M 0.02% 519
2024
Q2
$38.7M Buy
266,536
+31,181
+13% +$4.27M 0.01% 552
2024
Q1
$31.4M Sell
235,355
-17,964
-7% -$2.33M 0.01% 584
2023
Q4
$35M Buy
253,319
+9,806
+4% +$1.29M 0.01% 587
2023
Q3
$32.4M Sell
243,513
-10,088
-4% -$1.34M 0.01% 559
2023
Q2
$36.1M Buy
253,601
+24,276
+11% +$3.35M 0.01% 508
2023
Q1
$32.5M Sell
229,325
-15,223
-6% -$2.18M 0.01% 515
2022
Q4
$38.3M Buy
244,548
+32,637
+15% +$4.69M 0.02% 471
2022
Q3
$26.8K Sell
211,911
-17,800
-8% -$2.34M 0.01% 587
2022
Q2
$32.1K Sell
229,711
-6,999
-3% -$954K 0.01% 579
2022
Q1
$32.9M Sell
236,710
-59,978
-20% -$8.36M 0.02% 601
2021
Q4
$51M Sell
296,688
-27,274
-8% -$4.15M 0.03% 419
2021
Q3
$48.1M Buy
323,962
+13,888
+4% +$2.03M 0.02% 575
2021
Q2
$41.3M Buy
310,074
+52,671
+20% +$6.9M 0.02% 578
2021
Q1
$32.6M Sell
257,403
-20,103
-7% -$2.48M 0.02% 532
2020
Q4
$34.3M Buy
277,506
+159,535
+135% +$19.4M 0.02% 525
2020
Q3
$13.7M Sell
117,971
-57,485
-33% -$6.79M 0.01% 722
2020
Q2
$20.3M Buy
175,456
+7,129
+4% +$756K 0.02% 584
2020
Q1
$13M Sell
168,327
-21,728
-11% -$2.25M 0.01% 620
2019
Q4
$20.3M Buy
190,055
+10,071
+6% +$1.05M 0.02% 689
2019
Q3
$19.3M Buy
179,984
+211
+0.1% +$21.7K 0.02% 640
2019
Q2
$18.3M Buy
179,773
+1,343
+0.8% +$129K 0.02% 669
2019
Q1
$16M Buy
178,430
+8,705
+5% +$754K 0.01% 683
2018
Q4
$14.1M Sell
169,725
-116,473
-41% -$10.9M 0.01% 661
2018
Q3
$30.9M Buy
286,198
+20,169
+8% +$2.21M 0.02% 510
2018
Q2
$29.2M Sell
266,029
-30,204
-10% -$3.15M 0.02% 491
2018
Q1
$29.7M Buy
296,233
+92,630
+45% +$9.49M 0.03% 490
2017
Q4
$20.1M Sell
203,603
-50,557
-20% -$4.79M 0.02% 619
2017
Q3
$23.8M Sell
254,160
-37,414
-13% -$3.97M 0.02% 539
2017
Q2
$32.4M Sell
291,574
-768
-0.3% -$81.2K 0.03% 449
2017
Q1
$28.7M Buy
292,342
+8,700
+3% +$829K 0.03% 465
2016
Q4
$24.8M Buy
283,642
+960
+0.3% +$82.7K 0.03% 479
2016
Q3
$23.9M Buy
282,682
+38,278
+16% +$3.21M 0.03% 498
2016
Q2
$19.9M Sell
244,404
-33,453
-12% -$2.55M 0.02% 550
2016
Q1
$19.9M Buy
277,857
+78,829
+40% +$5.29M 0.02% 494
2015
Q4
$14.2M Buy
199,028
+51,673
+35% +$3.47M 0.02% 612
2015
Q3
$9.06M Sell
147,355
-4,768
-3% -$333K 0.01% 744
2015
Q2
$11M Sell
152,123
-46,394
-23% -$3.43M 0.01% 753
2015
Q1
$15.3M Buy
198,517
+45,448
+30% +$3.25M 0.02% 619
2014
Q4
$10.3M Buy
153,069
+35,629
+30% +$2.25M 0.01% 772
2014
Q3
$7.13M Sell
117,440
-7,595
-6% -$468K 0.01% 959
2014
Q2
$7.34M Buy
125,035
+11,254
+10% +$659K 0.01% 947
2014
Q1
$6.59M Sell
113,781
-4,403
-4% -$236K 0.01% 828
2013
Q4
$6.33M Buy
118,184
+5,323
+5% +$316K 0.01% 757
2013
Q3
$6.97M Buy
112,861
+63,032
+126% +$3.77M 0.01% 649
2013
Q2
$3.02M Buy
+49,829
New +$2.97M 0.01% 934

Other funds holding DGX

Bank of Montreal's DGX Position: Q1 2026 in Review

Bank of Montreal reduced its Quest Diagnostics (DGX) stake by 3.2% in Q1 2026, selling an estimated $1.36M and leaving 210,365 shares worth $41.2M. The position accounts for 0.02% of the portfolio, ranked #604.

Bank of Montreal first reported a position in DGX in Q2 2013 and has held it in 52 quarters since. The position peaked at $51M in Q4 2021. 1,066 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Bank of Montreal held 210,365 shares of Quest Diagnostics worth $41.2M as of Q1 2026.
  • Bank of Montreal sold 7,019 Quest Diagnostics shares in Q1 2026, an estimated $1.36M.
  • Quest Diagnostics made up 0.02% of Bank of Montreal's portfolio in Q1 2026, its #604 holding.
  • Bank of Montreal first reported a position in Quest Diagnostics in Q2 2013 and has held it in 52 quarters since.
  • Bank of Montreal's Quest Diagnostics position peaked at $51M in Q4 2021.
  • 1,066 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Bank of Montreal's 13F filing for Q1 2026, filed 13 May 2026.